Upload
others
View
3
Download
0
Embed Size (px)
Citation preview
Pharmaceutical Management and Scaling up MDR-TB Care Delivery: “Last mile” Challenges and Solutions
Andre Zagorski November 12, 2012
Kuala Lumpur
USAID-funded Systems for Improved Access to Pharmaceuticals and Services (SIAPS; follow up to RPM, RPM Plus, SPS)
Objectives of SIAPS TB portfolio: 1. Pharmaceutical Governance for TB strengthened at
Global Level and country level 2. Capacity for TB pharmaceutical supply management
and services increased and enhanced 3. Improved utilization of information for TB control
decision making 4. Improved financing strategies for expedited access to
new TB tools and pharmaceutical services 5. Improved pharmaceutical services and access to TB
products to achieve TB Goals
Challenges in pharmaceutical management for tuberculosis…
• Gap between the known and proven good pharmaceutical management practices, and their application by the global initiatives and NTPS
• Weak public health systems, including: • pharmaceutical regulation not supporting NTP needs • standards and delivery of pharmaceutical services: from
supply chains to patient • human resources capacity and leadership • pharmaceutical management information systems: lack of
valid data for forecasting and quantification • Weak management of finance: ranging from total lack of
funding for SLD to underutilization of available funds for IQA SLD
…resulting in:
• No access to IQA SLD in some countries
• Other countries, access to IQA SLDs limited despite the availability of funds and medicines from global initiatives (GF, GDF)
• Stock-outs and treatment interruptions (but little analysis available of the underlying reasons): • Forecasting and quantification mistakes
• Late procurement/ordering and delivery
• Country supply chain bottlenecks
• Expiry and waste of procured SLD
• Risky market for potential IQA SLD suppliers
• Forecasting
• Quantification
• Early Warning Systems roles: • Global: timely reactions to demand changes
• Country: preventing stock-outs and treatment interruptions
Stakeholders mobilization as solution
Forecasting for PMDT and scale-up
• Provides number and type of DR-TB cases that a health system can effectively diagnose and treat in a projected period
• Crucial for strategic planning (NTP, donors) and market shaping • Requires full TB program evaluation, including:
• reliability of case finding: diagnosis systems and their effectiveness, epidemiological data
• capacity of health system (staff, treatment facilities, etc.) • capacity of medicines supply system: registration and clearance of
medicines; distribution (storage and transportation); • inventory management practices and information management: stock
levels, consumption and pipeline data reporting, and stock-outs monitoring (“early warning system”)
• available funding
• Done for GF projects? WHO and GLC PMDT surveys? • Evaluation concerns and implementation of interventions
monitored?
Quantification • Quantities of each specific product to be procured or ordered
for a given period of time
• Crucial for continuous treatment of current cases and guaranteed start of treatment of to be diagnosed cases
• Requires ongoing data collection and processing, e.g.: • Actual number of cases on treatment by regimen (or % of each SLD
in regimens)
• Cases to be enrolled during the next period by regimen
• Actual consumption data (by product, by month, etc.)
• Medicines pipeline data (stock, pending deliveries, expiry data)
• Procurement lead times (order approval, placing, etc.)
• Finance lead times (disbursement, payment to suppliers)
• Done by GF, GLC, GDF consultants?
• Local capacity developed?
Early Warning of Stock-outs Systems: Solutions at country level
• Country early warning systems, which are not necessarily software-based, but rather a set of SOPs for collecting and processing data (data collection – part of supervision and regular R&R) = good inventory control practices
• Electronic solutions, e.g.: full e-TB Manager for quantification and inventory management (Brazil);
• utilization of only the quantification module (expand to inventory management module) on-line
• GDF and GF – mandatory (as a condition for support) quarterly reporting of case enrollment and medicines stock data – currently missing
A comprehensive web based application for strenghtening TB control programs by integrating case management, medicines inventory control, surveillance, and reporting into a single platform
Case notification and management
Medicines supply and stock control
Epidemiological surveillance / Reports Information
9
Solutions at the country level: Full Electronic System: e-TB Manager
Tools for countries: Forecasting and Quantification with e-TB Manager
Early Warning: How well-managed systems work (Brazil example) • Brazil FDA (Anvisa) inspected Terezidone manufacturing site (Fatol
/ Germany)
• Manufacturer was in process of moving production to a new plant
• Issues were raised by inspectors, and pending order was blocked by Anvisa creating a nationwide risk of shortage
• Immediately : • central level investigated all stock positions at all TCs with e-TBM
• buffer stocks levels for new distributions were decreased for better control of terezidone strategic stock at central level
• Stock-on-hand levels were calculated to inform MoH
• NTP sent a statement of real time risk of shortage with detailed data to Anvisa for releasing current pending order as a priority
• Impact on patients was averted
Solutions at Global Level – GDF
GDF as global clearinghouse (the GDF “value added”)
• Global forecast and market shaping, based on:
• Information from donors (e.g. the Global Fund)
• Pharmaceutical and treatment data collected during its own country TB surveys and monitoring missions, and by partners
• Interface for data reporting (developed, since 2005 based on orders data)
• Dedicated GDF and partners field officers monitoring countries and collecting data (in process)
• Quarterly data reporting by NTPs as a conditionality of the GDF support, for grants and direct procurement (in process)
• Open information sharing with partners (in process)
GDF Forecasting & Early Warning Systems Current situation Dashboards (slides provided by GDF)
Estimated stockouts risk 6 to 12 months – Dashboards SLDs Live Web report http://gva1swamphion/sree/Reports?op=vs&path=/WHO_HQ_Reports/G1/PROD/INT/Shared/t_GDF_Project2&userid=GDF_ro&password=gdfread1
Order Serial
Number
Quantiti es
Planned
Last Status
Change
Days in current status
Pending Action
KEN/GR/10/1575 1,588 24-Nov-10 716 Order placed with supplier(s)
BWA/DP/11/1889 1,600 15-Jun-11 513 Pending reception by procurement agent of client signed agreement
BWA/DP/11/1889 1,700 15-Jun-11 513 Pending reception by procurement agent of client signed agreement
BWA/DP/11/1889 2,100 15-Jun-11 513 Pending reception by procurement agent of client signed agreement
BWA/DP/11/1889 1,500 15-Jun-11 513 Pending reception by procurement agent of client signed agreement
BWA/DP/11/1889 1,600 15-Jun-11 513 Pending reception by procurement agent of client signed agreement
BWA/DP/11/1889 1,500 15-Jun-11 513 Pending reception by procurement agent of client signed agreement
BFA/GR/11/2085 331 8-Sep-11 428 Order placed with supplier(s)
ARM/DP/11/2178 50 19-Oct-11 387 Pending reception by procurement agent of client signed agreement
GIN/DP/11/2198 274 28-Oct-11 378 Pending reception by procurement agent of client signed agreement
GIN/DP/11/2197 225 28-Oct-11 378 Pending reception by procurement agent of client signed agreement
GIN/DP/11/2198 274 28-Oct-11 378 Pending reception by procurement agent of client signed agreement
GIN/DP/11/2197 274 28-Oct-11 378 Pending reception by procurement agent of client signed agreement
PLANNED DELIVERIES - Order not yet confirmed pending Action
GDF Global SLD PT supply
GDF Forecasting & Early Warning Systems Current situation Dashboards (cont. slides provided by GDF)
Country Stock Out Risk Index by Line
Country Name Line Estimated Risk Index in % Afghanistan MDR 100
Belize MDR 100
Botswana MDR 100
Burundi MDR 100
Costa Rica MDR 100
Liberia MDR 100
Lebanon MDR 100
Samoa MDR 100
Zimbabwe MDR 71
Bosnia and Herzegovina MDR 57
Thailand MDR 57
Uruguay MDR 57
Cuba MDR 57
Russian Federation MDR 36
Peru MDR 36
Lao People's Democratic Republic MDR 36
Latvia MDR 29
GDF Global SLD Stock out estimated risk at 6 to 12 months
Global Forecasting & Early Warning Systems: Gaps to be addressed by stakeholders/partners:
• Target – health system, not NTP alone
• Harmonized data collection and sharing by partners
• Global partners performing country surveys: e.g. GLC, technical agencies – include inventory control component
• Donor-supported field programs (use GDF interface)
• Data reporting as a condition for any country support (as the GF, GDF, other donors’ conditions of support)
• GDF/SIAPS pilot data collection to start in 11 countries (Africa)
Conclusions • Tools for collecting and processing data exist at the global
and country levels
• Most NTPs have inventory control mechanisms (recording stock, transactions, etc.) – but seldom linked with case management/treatment
• Technical agencies and/or bi-lateral donor programs are present in most high-burden countries (and most other countries with TB problems) • Should be involved in strengthening the capacity for data
collection and information management
• GDF is the best existing platform for coordination of stakeholders and harmonization of approaches to pharmaceutical services for MDR-TB scale-up